Chemotherapy for lymphatic filariasis: Progress but not perfection

Expert Review of Anti-Infective Therapy

Volumn 1, Issue 4, 2003, Pages 571-577

  Melrose, Wayne D ^a  

^a JAMES COOK UNIVERSITY   (Australia)

Author keywords

Albendazole; Chemotherapy; Diethylcarbamazine; Ivermectin; Lymphatic filariasis; Microfilaria

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINESTERASE; ACID PHOSPHATASE; ALBENDAZOLE; AMIDE; AMOCARZINE; ANDROGRAPHIS PANICULATA EXTRACT; ANTIFILARIAL AGENT; BENZOQUINONE DERIVATIVE; BENZOTHIAZOLE; BETA CARBOLINE DERIVATIVE; BETA GLUCURONIDASE; CARBAMAZEPINE; CGI 18041; CGP 30376; CHLORAMBUCIL; CHLORIDE ION; CLOSANTEL; CYCLOHEXANE DERIVATIVE; DOXYCYCLINE FOSFATEX; GINGER EXTRACT; IVERMECTIN; NEUROTRANSMITTER; NITRATE; NITRIC OXIDE; PIPERAZINE DERIVATIVE; SULFONAMIDE; TUBULIN; UBIQUINONE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CLINICAL TRIAL; DISEASE TRANSMISSION; DOSE RESPONSE; DRUG SAFETY; FILARIASIS; HUMAN; IN VITRO STUDY; INFECTION CONTROL; LIFE CYCLE; LIVER TOXICITY; LYMPHATIC SYSTEM DISEASE; MICROFILARIA; MOSQUITO; REVIEW; SYMBIONT; WORM;

EID: 3042744923     PISSN: 14787210     EISSN: None     Source Type: Journal    
DOI: 10.1586/14787210.1.4.571     Document Type: Review

References (85)

1. World Health Organisation. Building partnerships for lymphatic filariasis: strategic plan. World Health Organisation, Geneva, Switzerland (1999).
2. Melrose WD. Lymphatic filariasis - new insights into an old disease Int. J. Parasitol. 32, 947-960 (2002).
3. Cox FEG. Elimination of lymphatic filariasis as a public health problem. Parasitol. Today 16, 135 (2000).
4. Molyneux DH, Zagaria N. Lymphatic filariasis elimination: progress in global programme development. Ann. Trop. Med. Parasitol. 96(Suppl.), S15-S40 (2002).
5. James DM, Gillies HM. In: Human Antiparasite Drugs: Pharmacology and Usage. John Wiley and Sons, Brisbane, Australia (1985).
6. MacKenzie CD, Kron MA. Diethylcarbamazine: a review of its action in oncocerciasis, lymphatic filariasis and inflammation. Trop. Dis. Bull. 82, R1-R36 (1985).
7. Campbell WC, Rew RS. Chemotherapy of Parasitic Diseases. Plenum Press, NY, USA (1986).
8. Maizels RM, Denham DA. Diethylcarbamazine (DEC): immuno pharmacological interactions if an antifilarial drug. Parasitol. 105 (Suppl.), S49-S60 (1992).
9. Bhattacharya C, Singh RN, Misra S, Rathaur S. Diethylcarbamazine: effect on lysosomal enzymes and acetylcholine in Wuchereria Bancroftian infection. Trop. Med. Int. Health. 2, 686-690 (1997).
10. Taylor MJ, Cross HF, Mohammed AA, Trees AJ, Bianco AE. Susceptibility of Brugia malayi and Oncocerca lienalis microfilariae to nitric oxide and hydrogen peroxide in cell free culture and from IFN γ-activated macrophages. Parasitol. 112, 315-322 (1996).
11. Winkler S, El Menyawi, Floris-Linnau K, Graninger W. Short report: total serum levels of the nitric oxide derivatives nitrite/nitrate during microfilarial clearance in human filarial disease. Am. J. Trop. Med. Hyg. 59, 523-525 (1998).
12. Weil GJ, Sethumadhavan KVP, Santhanam S, Jain DC, Ghosh TK. Persistence of parasite antigenaemia following diethylcarbamazine therapy of Bancroftian filariasis. Am. J. Trop. Med. Hyg. 38, 589-595 (1988).
13. Figueredo- Silva, Jungman P, Noroes J et al. Histological evidence for adulticidal effect of low doses of diethylcarbamazine in Bancroftian filariasis. Trans. R. Soc. Trop. Med. Hyg. 90, 192-194 (1996).
14. Ismail MM, Weil GJ, Jayasinghe KS et al. Prolonged clearance of microfilaraemia in patients with Bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine. Trans. R. Soc. Trop. Med. Hyg. 90, 684-688 (1996).
15. Eberhard ML, Hightower AW, Addiss DG, Lammie MJ. Clearance of Wuchereria bancrofti antigen after treatment with diethylcarbamazine or ivermectin. Am. J. Trop Med. Hyg. 57, 483-486 (1997).
16. Wijers DJB. Bancroftian filariasis in Kenya V: mass treatment given by members of the local community. Ann Trop. Med. Parasitol. 78, 383-394 (1984).
17. Mataika JU, Kimura I, Koroivueta J, Shimada M. Efficacy of five annual single doses of diethylcarbamazine for treatment of lymphatic filariasis in Fiji. Bulletin of the World Health Organisation. 76, 557-579 (1998).
18. Taylor MJ, Turner PF. Control of lymphatic filariasis. Parasitol Today 13, 85-86 (1997).
19. Jing-yuan L, Xin-ji L, Zi C et al. Filariasis and its control in Fujian, China. Southeast Asian J. Trop. Med. Public Health 22, 147-154 (1991).
20. Jing-yuan L, Zi C, Xiao-hong H, Zhao-ping T. Mass treatment of filariasis using DEC-medicated salt. J. Trop. Med. Hyg. 95, 132-135 (1992).
21. Liu JY, Chen Z, Huang JH, Tu SP. Mass treatment of filariasis using DEC-medicated salt. J. Trop. Med. Hyg. 95, 132-135 (1992).
22. Krishnarao P, Kaur R, Ghosh TK. Long-term effect of diethylcarbamazine medicated common salt on bancroftian filariasis. J. Comm. Dis. 23, 128-130 (1991).
23. Michael E, Meyrowitsch DW Simonsen PE. Cost and cost effectiveness of mass diethylcarbamizine chemotherapy for the control of Bancroftian filariasis: comparison of four strategies in Tanzania. Trop. Med. Int. Health. 1, 414-426 (1996).
24. Meyrowitsch D, Simonsen PE. Long-term effect of mass diethylcarbamazine chemotherapy on bancroftian filariasis: results at four years after start of treatment. Trans. R. Soc. Trop. Med. Hyg. 92, 98-103 (1998).
25. Shenoy RK, Varghese J, Kuttikkal VV. The efficacy, tolerability and safety of diethylcarbamizine-fortified salt in the treatment of the microfilaraemias of brugian filariasis: an open, hospital based study. Ann. Tropical Med. Parasitol. 92, 285-293 (1998).
26. Forsyth K. New approaches to the control of lymphatic filariasis using diethylcarbamazine. PNG. Med. J. 30, 189-191 (1987).
27. Partono F, Purnomo A. Oemijati S, Soewarta A. The long-term effects of repeated diethylcarbamazine administration with special reference to microfilaraemia and elephantiasis. Acta. Trop. 38, 217-225 (1984).
28. Partono F, Maizels RM, Puromo S. Towards a filarial-free community: evaluation of filariasis control over an eleven year period in Flores, Indonesia. Trans. R. Soc. Trop. Med. Hyg. 83, 821-826 (1989).
29. Panicker KN, Krishnamoorthy K, Sabesan S, Prathiba J, Abidha K. Comparison of effects of mass annual and biannual single dose therapy with diethylcarbamazine for the control of Malyan filariasis. SE Asian J. Trop. Med. Public Health 22, 402-411 (1991).
30. Kimura E, Penania L, Spears GF. The efficacy of annual doses of diethylcarbamazine citrate against diurnally sub-periodic Bancroftian filariasis in Samoa. Bull. WHO 63, 1097-1106 (1985).
31. Hawking F, Sewell P, Thurston JP. The mode of action of hetrazan on filarial worms. Br. J. Pharmacol. 5, 217-238 (1950).
32. Zheng HJ, Tao ZH, Cheng WF et al. Efficacy of ivermectin for control of microfilaraemia recurring after treatment with diethylcarbamazine. 2. Immunologic changes following treatment. Am. J. Trop. Med. Hyg. 45, 175-181 (1991).
33. Zhong-Xing L, Zhong-Jun S. A field survey on the role of low-density microfilaraemia cases in the transmission of filariasis. SE Asian J. Trop. Med. Public Health 20, 153-156 (1989).
34. Eberhard MI, Dickinson CM, Hightower AW, Lammie MJ. Bancroftian filariasis: long-term effects of treatment with diethylcarbamizine in a Haitian population. Am. J. Trop. Med. Hyg. 45, 728-733 (1991).
35. Turner W, Schaeffer JM. Mode of action of Ivermectin. In: Ivermectin and Abamectin. Campbell WC (Ed.), Springer-Verlag, NY, USA (1989).
36. Goa KL, McTavish D, Clissold SP. Ivermectin: a review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis. Drugs 42, 640-648 (1991).
37. Kumaraswami V, Ottesen EA, Vijayasekaran V. Ivermectin for the treatment of Wuchereria bancrofti filariasis:efficacy and adverse reactions. JAMA 259, 3150-3153 (1988).
38. Ottesen EA, Campbell WC. Ivermectin in human medicine. J. Antimicrobial. Chem. 34, 195-203 (1994).
39. Ottesen EA, Ramachandran CP. Lymphatic filariasis infection and disease: control strategies. Parasitol. Today 11, 129-131 (1995).
40. Zheng HJ, Piessens WF, Tao ZH et al. Efficacy of ivermectin for control of microfilaraemia recurring after treatment with diethylcarbamazine. I. Clinical and parasitological observations. Am. J. Trop. Med. Hyg. 45, 168-174 (1991).
41. Addiss DG, Eberhard ML, Lammie PL. Comparative efficiency of clearing-dose and single high-dose ivermectin and diethylcarbamazine against Wuchereria bancrofti microfilaraemia. Am. J. Trop. Med. Hyg. 48, 178-185 (1993).
42. Kazura J, Greenberg J, Perry R, Weil G, Day K, Alpers M. Comparison of single-dose diethylcarbamazine and ivermectin for the treatment of Bancroftian filariasis in Papua New Guinea. Am. J. Trop. Med. Hyg. 49, 804-811 (1993).
43. Moulia-Pelat JP, Nguyen LN, Glaziou P, Chanteau S, Gay VM, Martin PMV, Cartel JL. Safety trial of single-dose treatments with a combination of ivermectin and diethylcarbamazine in Bancroftian filariasis. Trop. Med. Parasitol. 44, 79-82 (1993).
44. Nguyen NL, Moulia-Pelat JP, Cartel JL. Control of lymphatic filariasis in an endemic area of Polynesia by ivermectin 400 micrograms/kg. Trans. R. Soc. Trop. Med. Hyg. 90, 689-691 (1996).
45. Smail MM, Weil GJ, Jayasinghe KS et al. Prolonged clearance of microfilaraemia in patients with Bancroftian filariasis after multiple high doses of ivermectin of diethylcarbamazine. Trans. R. Soc. Trop. Med. Hyg. 90, 684-688 (1996).
46. Dreyer G, Amaral F, Noroes J Nen A, Medeiros Z, Coutinho A, Addiss D. Direct assesment of the adulticidal efficiency of a single dose of ivermectin in lymphatic filariasis. Trans. R. Soc. Trop. Med. Hyg. 89, 441-443 (1995).
47. Dreyer G, Noroes J, Amaral F, Medeiros Z, Addiss D. A new tool to assess the adulticidal efficacy in vivo of antifilarial drugs for Bancroftian filariasis. Trans. R. Soc. Trop. Med. Hyg. 89, 225-226 (1995).
48. Dreyer G, Addiss D, Noroes J, Amaral F, Rocha A, Coutinho A. Ultrasonic assessment of the adulticidal efficacy of repeat high-dose ivermectin in Bancroftian filariasis. Trop. Med. Int. Health. 1, 427-432 (1996).
49. Lacey E, Brady RL, Pritchard RK, Watson TR. Comparison of inhibition of polymerase of mammalian tubulin: helminth ovicidal activity by benzimidazole carbamates. Vet. Parasitol. 23, 105-119 (1987).
50. Oxberry ME, Geary TG, Winterrowd CA, Pritchard RK. Individual expression of recombinant α- and β-tuberlin from Haemonchus contortus: polymerization and drug effects. Protein Expr. Purif. 21, 30-39 (2001).
51. Horton J. Albendazole: a broad spectrum anthelminthic for the treatment of individuals and populations. Curr. Opin. Infect. Dis. 15, 599-608 (2002).
52. Ottesen EA, Ismail MM, Horton J. The role of Albendazole in programmes to eliminate lymphatic filariasis. Parasitol. Today 15, 382-386 (1999).
53. Moulia-Pelat JP, Nguyen LN, Glaziou P et al. Safety trial of single-dose treatments with a combination of ivermectin and diethylcarbamazine in Bancroftian filariasis. Trop. Med. Parasitol. 44, 79-82 (1993).
54. Moulia-Pelat JP, Glaziou P, Chanteau S et al. Periodicity of Wuchereria bancrofti var Pacifica filariasis in French Polynesia. Trop. Med. Parasitol. 44, 83-85 (1993).
55. Moulia-Pelat JP, Nguyen LN, Glaziou P et al. Ivermectin 400 μg/kg: long-term suppression of microfilaraemia in Bancroftian filariasis. Trans. R. Soc. Trop. Med. Hyg. 88, 107-109 (1994).
56. Moulia-Pelat JP, Nguyen LN, Glaziou P et al. Ivermectin plus diethylcarbamazine: an additive effect on early microfilariae clearance. Am. J. Trop. Med. Hyg. 50, 206-209 (1994)
57. Moulia-Pelat JP, Glaziou PH, Weil GJ, Nguyen LN, Gaxotte PH, Nicolas L. Combination ivermectin plus diethylcarbamazine, a new effective tool for control of lymphatic filariasis. Trop. Med. Parasitol. 46, 9-12 (1995).
58. Nicolas L, Plichart C, Nguyen NL, Moulia-Pelat JP. Reduction of Wuchereria bancrofti adult worm circulating antigen after annual treatments of diethylcarbamazine combined with ivermectin in French Polynesia. J. Infect. Dis. 175, 489-492 (1997).
59. Addiss DG, Beach MJ, Streit TG et al. Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children. Lancet 350, 480-484 (1997).
60. Ismail MM, Premaratne UN, Abeyewickreme W. Treatment of Bancroftian filariasis with ivermectin in Sri Lanka: evaluation of efficacy and adverse reactions. Trop Biomed. 8, 71-75 (1991).
61. Ismail MM, Weil GJ, Jayasinghe KS et al. Prolonged clearance of microfilaraemia in patients with Bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine. Trans. R. Soc. Trop. Med. Hyg. 90, 684-688 (1996).
62. Ismail MM, Jayakody RL, Weil GJ et al. Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of Bancroftian filariasis. Trans. R. Soc. Trop. Med. Hyg. 92, 94-97 (1998).
63. Training module on lymphatic filariasis for drug distributors in non-onchocerciasis co-endemic countries. WHO (2000).
64. The programme to eliminate lymphatic filariasis. Essential elements for medical personnel in onchocerciasis co-endemic countries. WHO (2000).
65. Dreyer G, Addiss D, Roberts J, Noroes J. Progression of lymphatic vessel dilation in the presence of living Wuchereria bancrofti. Trans. R. Sco. Trop. Med. Hyg. 96, 157-161 (2002).
66. Lazdins J, Kron M. New molecular targets for filariasis drug discovery. Parasitol. Today 15, 305-306 (1999).
67. Mak JW, Navaratnam V, Ramachandran CP. Experimental chemotherapy of lymphatic filariasis. A review. Ann. Trop. Med. Parasitol. 85, 131-137 (1991).
68. Gayral P, Loiseau PM, Bories C, Brienne MJ, Leclercq M, Jacques J. In vitro and in vivo antifilarial activity of ethynesulfonamides, epoxyethanesulfonamides and carboxamide analogues. Arzneimittelforschung 45, 1122-1127 (1995).
69. Loiseau PM, Depreux P. In vitro antifilarial evaluation of phenoxycyclohexane derivatives. Ann. Trop. Med. Parasitol. 87, 469-476 (1993).
70. Srivastava SY, Agarwal A, Chauhan PM, Agarwal SK, Bhaduri AP, Singh SN, Fatima N, Chatterjee RK. Potent 1,3-substituted-9H-pyridol [3,4-B] indoles as new lead compounds in antifilarial chemotherapy. Bioorgan. Med. Chem. 7, 1223-1236 (1999).
71. Sundberg RJ, Biswas S, Kumar Murthi K, Rowe D, McCall JW, Dzimianski MT. Bis-cationic hetero aromatics as macrofilaricides: synthesis of bis-amidine and bis-guanylhydrazone derivatives of substituted imidazo[1,2-A]pyridines. J. Med. Chem. 41, 4317-432 (1998).
72. Varma Rajendra S, Sarin S, Chatterjee RK. Synthesis of beta-amino substituted 4-amino-3-nitropropiophenones as diethylcarbamazine analogs and their antifilarial activity. Ind. J. Chem. 31, 711-713 (1992).
73. Sivan VM, Rai RK. Quinone analogue irrecoverably paralyses the filarial parasites in vitro. Biochem. Biophys Res. Commun. 256, 81-83.
74. Monzon RB. Traditional medicine in the treatment of parasitic diseases in the Philippines. Southeast Asian J. Trop. Med. Public Health 26, 421-428 (1995).
75. Dutta A, Sukul N. Filariacidal properties of a wild herb Andrographis paniculata. J. Helminthol. 56, 81-84 (1982).
76. Dutta A, Sukul N. Antifilarial effect of Zingiber officinale on Dirofilaria immitis. J. Helminthol. 61, 268-270 (1987).
77. Singh SN, Bhatnagar S, Fatma N, Chauhan PMS, Chatterjee RK. Antifilarial activity of a synthetic marine alkaloid, aplysinopsin (CDRI compound 92/138). Trop. Med. Int. Health 2, 535-543 (1997).
78. Loiseau PM, Bourass J, Letourneux Y. Lymphotrophic antifilarial agents derived from closantel and chlorambucil. Int. J. Parasitol. 27, 443-447 (1997).
79. Hoerauf A, Nissen-Pahle K, Schmetz C et al. Tetracycline therapy targets intracellular bacteria in the filarial nematode Litomosoides sigmodontis and results in filarial infertility. J. Clin. Invest. 103, 11-18 (1999).
80. Hoerauf A, Volkmann L, Hamelmann C, Adjei O, Autenrieth I, Fleischer B, Buttner DW. Endosymbiotic bacteria in worms as targets for a novel chemotherapy for filariasis. Lancet 355, 211-213 (2000).
81. Taylor MJ, Hoerauf A. Wolbachia bacteria of filarial nematodes. Parasitol. Today 15, 437-442 (1999).
82. Taylor MJ. Wolbachia bacteria of filarial nematodes in the pathogenesis of disease and as a target for control. Trans. R. Soc. Trop. Med. Hyg. 94, 596-598 (2000).
83. Townson H. Wolbachia as a potential tool for suppressing filarial transmission. Ann. Trop. Med. Parasitol. 96(Suppl.), S117-S127 (2002).
84. Doxycyline as a novel strategy against bancroftian filariasis - depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production. Med. Microbiol Immunol (Berl). (Epub ahead of print).
85. Control of filarial infections: not the beginning of the end but more research is needed. Curr. Opin. Infect. Dis. 16, 403-410 (2003).